Roswell Park Appoints Chair of Cancer Genetics and Genomics

Dr. John Krolewski is leader in pathogenesis of prostate cancer, personalized medicine
Monday, April 3, 2017
Highlights: 
John Krolewski, MD, PhD, named Chair of Cancer Genetics and Genomics
Dr. Krolewski joined Roswell Park in 2015 from the University of Rochester
Will lead program focused on understanding how cancer arises

BUFFALO, N.Y. — John Krolewski, MD, PhD, has been appointed as Chair of the Department of Cancer Genetics and Genomics and Co-Leader of the Cancer Center Support Grant (CCSG) Genetics and Genomics Program at Roswell Park Cancer Institute. He will also hold the John & Santa Palisano Endowed Chair of Cancer Genetics and Genomics. Dr. Krolewski has served as Interim Chair of the Department of Genetics and Interim Leader of the CCSG Genetics Program at Roswell Park since March 2016.

“Dr. Krolewski brings a great mix of leadership, inspiration, operational experience and scientific excellence to this position. We look forward to his leadership as we continue to build the department and the CCSG program,” says Kunle Odunsi, MD, PhD, Deputy Director of Roswell Park Cancer Institute.

Prior to coming to Roswell Park in 2015, Dr. Krolewski was a faculty member with research and mentorship roles at Columbia University (1990–1998), the University of California, Irvine (1998–2012), and the University of Rochester (2012–2015). He served in several leadership positions at these institutions including: Co-Leader of the Carcinogenesis Program at the Chao Family Comprehensive Cancer Center, UC Irvine; Professor and Chair of Pathology and Laboratory Medicine at the U of R; and Leader of the Solid Tumor Program at the Wilmot Cancer Institute at the U of R.

The Department of Cancer Genetics and Genomics at Roswell Park is dedicated to improving our understanding of mechanisms and pathways through which cells change to become cancer cells. Identifying genes and pathways involved in cell cycle control will improve our understanding of cancer and can lead to innovative new personalized therapies.

###

The mission of Roswell Park Cancer Institute (RPCI) is to understand, prevent and cure cancer. Founded in 1898, RPCI is one of the first cancer centers in the country to be named a National Cancer Institute-designated comprehensive cancer center and remains the only facility with this designation in Upstate New York. The Institute is a member of the prestigious National Comprehensive Cancer Network, an alliance of the nation’s leading cancer centers; maintains affiliate sites; and is a partner in national and international collaborative programs. For more information, visit www.roswellpark.org, call 1-877-ASK-RPCI (1-866-559-4838) or email askrpci@roswellpark.org. Follow Roswell Park on Facebook and Twitter.

Media Contact: 

Deborah Pettibone, Public Information Specialist
716-845-4919; deborah.pettibone@roswellpark.org